The emergency use authorization for COVID‐19 convalescent plasma reduced mortality-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The emergency use authorization for COVID‐19 convalescent plasma reduced mortality

Published:2023-08 Issue:8 Volume:6 Page:
ISSN:2398-8835
Container-title:Health Science Reports
language:en
Short-container-title:Health Science Reports

Author:

Paneth Nigel¹^ORCID,Casadevall Arturo²,Joyner Michael³

Affiliation:

1. College of Human Medicine Michigan State University East Lansing Michigan USA

2. Department of Molecular Microbiology & Immunology The Johns Hopkins University Baltimore Maryland USA

3. Department of Anesthesiology The Mayo Clinic Rochester Minnesota USA

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/hsr2.1463

Reference7 articles.

1. The evidence base for emergency use authorizations for COVID‐19 treatments: A rapid review

2. Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19

3. Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19

4. Is convalescent plasma futile in COVID-19? A Bayesian re-analysis of the RECOVERY randomized controlled trial

5. Convalescent plasma use in the USA was inversely correlated with COVID-19 mortality

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The value of observational registry studies for the next infectious disease emergency;mBio;2023-12-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3